XML 42 R22.htm IDEA: XBRL DOCUMENT v2.4.1.9
Preferred Stock, Common Stock and Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2014
Equity [Abstract]  
Summary of Warrants Activity

  A summary of the Company’s warrant activity is as follows:

Summary of Stock Option Activity

A summary of the Company’s stock option activity under the 2007 Plan and 2013 Plan is as follows:

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

Exercise

 

 

Contractual

 

 

Aggregate

 

 

 

Shares

 

 

Price

 

 

Term (Years)

 

 

Intrinsic Value

 

Outstanding at December 31, 2013

 

 

624,750

 

 

$

7.61

 

 

 

8.41

 

 

$

869,490

 

Granted

 

 

64,000

 

 

$

7.65

 

 

 

9.35

 

 

 

Exercised

 

 

(5,250

)

 

$

0.29

 

 

 

2.70

 

 

$

33,810

 

Expired/Forfeited

 

 

 

 

 

 

 

 

Outstanding at December 31, 2014

 

 

683,500

 

 

$

7.67

 

 

 

8.45

 

 

$

649,000

 

Vested and expected to vest at December 31, 2014

 

 

683,500

 

 

$

7.67

 

 

 

8.45

 

 

$

649,000

 

Exercisable at December 31, 2014(1)

 

 

259,081

 

 

$

5.47

 

 

 

7.65

 

 

$

631,231

 

 

Includes awards with early exercise provisions that permit optionee to exercise unvested options.

Summary of Nonvested Options Activity

The Company had the following nonvested options under the 2007 Plan and 2013 Plan:

 

 

 

Shares

 

 

Weighted

Average

Grant Date

Fair Value

Per Share

 

Nonvested at December 31, 2013

 

 

534,210

 

 

$

8.84

 

Granted

 

 

64,000

 

 

$

4.76

 

Vested

 

 

(173,791

)

 

$

7.96

 

Expired/Forfeited

 

 

 

 

Nonvested at December 31, 2014

 

 

424,419

 

 

$

9.02

 

 

Summary of Estimated Fair Value of Stock Option Award

The estimated fair value of each option award granted was determined on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions for options grants during the two years ended December 31, 2014:  

 

 

 

Year Ended December 31,

 

 

 

2014

 

 

2013

 

Risk free interest rate

 

1.66% - 1.77%

 

 

1.75% - 1.8%

 

Expected option term

 

5.5 - 6.0 years

 

 

6.0 years

 

Expected volatility of common stock

 

71.06% - 73.21%

 

 

70.8% - 79.4%

 

Expected dividend yield

 

 

0.00%

 

 

 

0.00%

 

 

Summary of Estimated Fair Value of Employee Stock Purchase Plan Award

The estimated fair value of the shares to be acquired under the ESPP was determined on the initiation date of each six month purchase period using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions for ESPP shares to be purchased during the year ended December 31, 2014:

 

 

 

Year Ended December 31,

 

 

 

2014

 

 

2013

 

Risk free interest rate

 

0.05% - 0.08%

 

 

 

 

Expected term

 

6.0 months

 

 

 

 

Expected volatility of common stock

 

69.32% - 73.21%

 

 

 

 

Expected dividend yield

 

 

0.00%

 

 

 

 

 

Summary of Recognized Non-Cash Stock-Based Compensation Expense

 

The Company recognized non-cash stock-based compensation expense to employees and directors in its research and development and its general and administrative functions as follows:

 

 

 

Year Ended December 31,

 

 

 

2014

 

 

2013

 

Research and development

 

$

410,150

 

 

$

39,638

 

General and administrative

 

 

691,937

 

 

 

106,328

 

Total stock-based compensation expense

 

$

1,102,087

 

 

$

145,966

 

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following at December 31, 2014 and 2013:

 

 

 

December 31,

 

 

 

2014

 

 

2013

 

Stock options issued and outstanding

 

 

683,500

 

 

 

624,750

 

Authorized for future option grants

 

 

188,370

 

 

 

8,500

 

Warrants to purchase common stock

 

 

118,881

 

 

 

106,000

 

Authorized for employee stock purchase plan

 

 

52,706

 

 

 

30,000

 

Total common stock reserved for future issuance

 

 

1,043,457

 

 

 

769,250